Breaking barriers in Alzheimer’s disease with focused ultrasound
Posição atual:
> This Story

starstarstarstarstar (1)
Início de uma sessão ou Registo to rate this News Story
Forward Printable StoryPrint Comment




More Magazine Features

A look back at the remarkable career of Ed Sloan Sr. Celebrating the life and career of the original parts vendor

The value of ISOs in an era of personalization and consolidation The unique value proposition of high quality third-party service

What to look for in an OEM service contract Communication the unique needs of your facility is key to getting the right coverage

The road ahead for breast density awareness It's been a good year for advocacy, here's what happens next

OB/GYN ultrasound: is the field ready to adopt new technology in the market? What do new capabilities mean for creatures of habit?

See All Magazine Features  

Ultrasound Homepage

Terason to integrate DiA cardiology AI in point-of-care ultrasounds Offer more accurate and objective imaging assessments

New study calls for prebiopsy MR scans in prostate cancer assessment Better able to detect cancers that likely require treatment

Dense breast laws not boosting ultrasound screening rates: study Researchers suggest risk of overdiagnosis may outweigh benefits in some cases

Ultrasound tomography system provides greater insight than conventional ultrasound Produces optical acoustic and laser ultrasound images

FUJIFILM SonoSite, Partners HealthCare to enhance point-of-care ultrasound with AI partnership Open access to affordable point-of-care ultrasound

Neurologica agrees to discounts for Strategic Radiology members Discounts on digital radiography and ultrasound, software and services

Global breast ultrasound market expected to reach $1.7 billion by 2023 Driven by novel vendor techniques, machine learning and deep-learning algorithms

OB/GYN ultrasound: is the field ready to adopt new technology in the market? What do new capabilities mean for creatures of habit?

The role of OB/GYNs in delivering personalized breast care Informed care requires an individual approach

Hologic puts forth $85 million offer to buy SuperSonic Imagine An entry into cart-based breast ultrasound market

Breaking barriers in Alzheimer’s disease with focused ultrasound

From the April 2019 issue of DOTmed HealthCare Business News magazine

By Ying Meng and Nir Lipsman

Few among us have been untouched in some way by Alzheimer’s disease (AD).
Whether a parent or grandparent, in the clinic or at home, the challenges of the disease and the toll it takes on patients and their families is significant, and only expected to grow. According to recent statistics from the United States, AD is the only top 10 cause of death that cannot be prevented, cured or slowed. Such sobering facts highlight that despite significant advances in our understanding of its pathophysiology, genetics and brain imaging, we are still far from effective disease-modifying therapies.

However, as we look to the future, novel treatments, such as focused ultrasound (FUS), continue to be investigated as technology that may one day help close this “therapeutic gap”. FUS uses the power of ultrasound waves to influence pathways deep inside the brain without needing traditional surgery or scalpels.
Story Continues Below Advertisement


Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.

Barriers to progress
The challenges of therapeutic development in AD are many, and range from our evolving understanding of its pathology, to designing clinical trials, detecting the disease at an early stage, and defining meaningful outcomes. Recognized now for decades as being, perhaps, the largest challenge: the blood brain barrier (BBB). The BBB is a feature unique to the central nervous system, and is a physical barrier, composed of tightly bound cells and processes that line the surface of fine capillaries within the brain. The BBB restricts the passage of large molecules, including potential therapeutics, into the brain, and expels certain drugs that do make it past the BBB. In cases where therapeutics do cross, failure to do so efficiently or at clinically meaningful concentrations is an important reason for poor treatment responses. In conjunction with developing targeted and effective pharmaceutical options, there is an urgent need to develop ways to enhance their delivery across the BBB, to where they are needed most, directly at the site of pathology.

Promising science
Safely and effectively overcoming the BBB has been a target of researchers for decades. To date, most attempts have required an operation, inserting catheters into the brain and infusing agents at high concentrations, as a way to “overwhelm” the barrier. Researchers at Sunnybrook Health Sciences Centre in Toronto, Canada have developed an entirely different approach, utilizing low-frequency focused ultrasound, that is noninvasive, does not require surgery or implants, and that is able to open the BBB quickly, safely and reversibly. Pioneered by Dr. Kullervo Hynynen, at Sunnybrook, this technology takes advantage of the oscillation of preformed inert microbubbles, which, when exposed to ultrasound rapidly oscillate, and cause a physical opening in the BBB that is temporary. Focused ultrasound circumvents many of the challenges of previous BBB technology, as it is image-guided, occurs in real-time, and leads to closure of the BBB within hours of the procedure.
  Pages: 1 - 2 - 3 >>

Ultrasound Homepage

You Must Be Logged In To Post A Comment